POP Biotechnologies

11:45 AM - 12:00 PM (PDT), Tuesday, June 14, 2022
POP Biotechnologies (POP BIO) is a clinical-stage biotechnology company dedicated to resolving areas of critical medical need in oncology and infectious disease. POP BIO's Spontaneous Nanoliposome Antigen Particleization (SNAP) vaccine platform provides a better way to create subunit vaccines and immunotherapies. The SNAP technology is a highly efficient approach for the rapid development of nanoparticle vaccines, effortlessly binding one or more antigens with orders of magnitude greater immune response, providing a versatile and powerful means to efficiently create vaccines.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
SNAP Vaccine Platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Director, Vaccine Development
POP Biotechnologies